News

NovoCure: Loading Up On Growth Catalysts
NovoCure's Q1 beat, Optune Lua momentum, and global expansion signal strong growth ahead. Find out why NVCR stock is a buy.
A Rare Signal for the S&P 500 -- Its 15th in the Last 75 Years -- Points to the Stock Market Skyrocketing Over the Next 5 Years
In April, the mature stock-driven Dow Jones Industrial Average ( ^DJI -0.61%), benchmark S&P 500 ( ^GSPC -0.67%), and ...